Results 181 to 190 of about 37,664 (239)

Erdafitinib in Patients with FGFR-Altered Advanced or Metastatic Cholangiocarcinoma. [PDF]

Clin Cancer Res
Pant S, Park JO, Su WC, Loriot Y, Carranza O, Corassa M, Doi T, Qin S, Tabernero J, Prenen H, Folprecht G, Winter H, Dal Molin GZ, Shen L, Qian J, Liao H, Thomas S, Sweiti H, Triantos S, Feng YH.   +19 more
europepmc   +1 more source

Bile acids enrichment fuel tumor aerobic glycolysis and immune evasion via stabilizing FXR-RARα. [PDF]

Front Immunol
Jiang H, Xiong W, Feng Y, Li X, Tan J, Zhang Z.   +5 more
europepmc   +1 more source

Identification of novel FGFR2::TXLNB Fusion in a polymorphous low-grade neuroepithelial tumor of the young. [PDF]

Brain Pathol
Hu SS, Tan TY, Yan W, Wang B.
europepmc   +1 more source

Correction: FGFR2/STAT3 signaling pathway involves in the development of MMTV-related spontaneous breast cancer in TA2 mice. [PDF]

Front Oncol
Du J, Zhao Q, Liu K, Li Z, Fu F, Zhang K, Zhang H, Zheng M, Zhao Y, Zhang S.   +9 more
europepmc   +1 more source

Phase III trial of infigratinib versus gemcitabine/cisplatin in adults with advanced cholangiocarcinoma with FGFR2 gene fusion or rearrangement: results and reflections on early termination of PROOF 301. [PDF]

ESMO Open
Abou-Alfa GK, Borbath I, Roychowdhury S, Goyal L, Lamarca A, Macarulla T, Shroff RT, Oh DY, Tamaş C, Savastano DM, van Veenhuyzen DF, Xu C, Freas E, Solanas J, Javle MM.   +14 more
europepmc   +1 more source

Correction to "Sprouty2 Suppresses Progression and Correlates to Favourable Prognosis of Intrahepatic Cholangiocarcinoma via Antagonizing FGFR2 Signalling". [PDF]

J Cell Mol Med
europepmc   +1 more source

DyVarMap: Integrating Conformational Dynamics and Interpretable Machine Learning for Cancer-Associated Missense Variant Classification in FGFR2. [PDF]

Bioengineering (Basel)
Lian Y, Shehu A.
europepmc   +1 more source

Circular RNA circSmad4 controls pulmonary fibrosis. [PDF]

Korean J Physiol Pharmacol
Jeong A, Kook T, Lee YG, Lim Y, Han A, Kim YK, Jeong D, Park WJ, Kwon DH, Kook H.   +9 more
europepmc   +1 more source

Uralenol, Glycyrol, and Abyssinone II as potent inhibitors of fibroblast growth factor receptor 2 from anti-cancer plants: A deep learning and molecular dynamics approach. [PDF]

PLoS One
Hossain A, Hossan MS, Prodhan MS, Joy MNH, Siam MR, Rahman ME, Matin MN.   +6 more
europepmc   +1 more source